AnaptysBio Inc (ANAB)
25.52
+0.26
(+1.03%)
USD |
NASDAQ |
May 15, 15:27
AnaptysBio Total Liabilities (Quarterly): 358.06M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 358.06M |
December 31, 2023 | 364.29M |
September 30, 2023 | 366.94M |
June 30, 2023 | 368.65M |
March 31, 2023 | 360.70M |
December 31, 2022 | 348.28M |
September 30, 2022 | 340.88M |
June 30, 2022 | 299.54M |
March 31, 2022 | 294.42M |
December 31, 2021 | 286.64M |
September 30, 2021 | 40.73M |
June 30, 2021 | 40.84M |
March 31, 2021 | 14.48M |
December 31, 2020 | 19.82M |
September 30, 2020 | 24.51M |
June 30, 2020 | 20.31M |
March 31, 2020 | 23.67M |
December 31, 2019 | 30.19M |
September 30, 2019 | 30.61M |
Date | Value |
---|---|
June 30, 2019 | 31.73M |
March 31, 2019 | 26.07M |
December 31, 2018 | 22.63M |
September 30, 2018 | 23.44M |
June 30, 2018 | 21.04M |
March 31, 2018 | 20.31M |
December 31, 2017 | 21.78M |
September 30, 2017 | 20.59M |
June 30, 2017 | 21.23M |
March 31, 2017 | 21.00M |
December 31, 2016 | 22.91M |
September 30, 2016 | 11.08M |
June 30, 2016 | 14.10M |
March 31, 2016 | 12.94M |
December 31, 2015 | 13.94M |
September 30, 2015 | 15.30M |
June 30, 2015 | 16.44M |
December 31, 2014 | 19.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.48M
Minimum
Mar 2021
368.65M
Maximum
Jun 2023
183.26M
Average
163.74M
Median
Total Liabilities (Quarterly) Benchmarks
XOMA Corp | 137.08M |
Fate Therapeutics Inc | 143.78M |
Ocular Therapeutix Inc | 130.96M |
Apellis Pharmaceuticals Inc | 565.25M |
Sutro Biopharma Inc | 321.09M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 405.84M |
Shareholders Equity (Quarterly) | 47.78M |
Current Ratio | 11.53 |